Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA.
David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642, USA.
Cells. 2024 May 16;13(10):844. doi: 10.3390/cells13100844.
Immune cell migration is required for the development of an effective and robust immune response. This elegant process is regulated by both cellular and environmental factors, with variables such as immune cell state, anatomical location, and disease state that govern differences in migration patterns. In all cases, a major factor is the expression of cell surface receptors and their cognate ligands. Rapid adaptation to environmental conditions partly depends on intrinsic cellular immune factors that affect a cell's ability to adjust to new environment. In this review, we discuss both myeloid and lymphoid cells and outline key determinants that govern immune cell migration, including molecules required for immune cell adhesion, modes of migration, chemotaxis, and specific chemokine signaling. Furthermore, we summarize tumor-specific elements that contribute to immune cell trafficking to cancer, while also exploring microenvironment factors that can alter these cellular dynamics within the tumor in both a pro and antitumor fashion. Specifically, we highlight the importance of the secretome in these later aspects. This review considers a myriad of factors that impact immune cell trajectory in cancer. We aim to highlight the immunotherapeutic targets that can be harnessed to achieve controlled immune trafficking to and within tumors.
免疫细胞的迁移对于产生有效和强大的免疫反应是必需的。这个优雅的过程受到细胞和环境因素的调节,免疫细胞的状态、解剖位置和疾病状态等变量决定了迁移模式的差异。在所有情况下,一个主要因素是细胞表面受体及其配体的表达。对环境条件的快速适应部分取决于内在的细胞免疫因素,这些因素影响细胞适应新环境的能力。在这篇综述中,我们讨论了髓系和淋巴系细胞,并概述了控制免疫细胞迁移的关键决定因素,包括免疫细胞黏附所需的分子、迁移模式、趋化性以及特定趋化因子信号。此外,我们总结了肿瘤特异性因素有助于免疫细胞向癌症的转移,同时还探讨了微环境因素可以以促进和抑制肿瘤的方式改变肿瘤内这些细胞的动态。具体来说,我们强调了分泌组在这些方面的重要性。本综述考虑了影响癌症中免疫细胞轨迹的众多因素。我们旨在强调可以利用免疫治疗靶点来实现对肿瘤内外的免疫细胞的控制性迁移。
Cells. 2024-5-16
Front Immunol. 2018-9-25
Adv Exp Med Biol. 2020
Cancer Immunol Res. 2014-12
J Immunother Cancer. 2020-4
Immunobiology. 2015-2
Am J Physiol Cell Physiol. 2015-11-1
ACS Appl Mater Interfaces. 2025-6-18
Res Sq. 2024-11-15
Signal Transduct Target Ther. 2024-10-18
Nat Immunol. 2024-5
Int J Hematol. 2024-5
Cells. 2024-2-14